SUMMARY:
·
Primary Complaint: Nasal Adenocarcinoma (biopsy diagnosis)
· Assessment: Neelix’s assessment confirms the presence of
a nasal adenocarcinoma. We discussed the
biologic behavior as locally aggressive with a low potential for metastasis. We discussed staging with chemistry/CBC/UA,
thoracic radiographs +/- abdominal ultrasound. Local therapy with radiation is the treatment of choice (Linear
Accelerator or Cyber Knife) but systemic treatment options including chemotherapy
(alternating doxorubicin and carboplatin has proven efficacy in a small number
of dogs but has not been evaluated in cats), metronomic therapy, or Piroxicam
alone are also reasonable. Additionally,
symptomatic therapies can be instituted.
Plan: Chemistry/CBC is pending. Owner is considering staging tests and
therapeutic options
History: Neelix presented for evaluation of recently diagnosed nasal adenocarcinoma.
The owners noticed a swelling on the right side of Neelix’s nose in early
October 2013. He was otherwise acting normally. The owners monitored it for a
couple weeks thinking it might be an abscess or bite of some kind. There was no
change in the mass and he was seen by a local veterinarian for the mass in
mid-October. He seemed uncomfortable when his mouth was opened and swatted at
the doctor and owner. A tooth root abscess was suspected and he was started on
a 10 day course of azithromycin. There was no change in the mass on the
antibiotics. (Evaluation 10-29-13). A Cryptococcus titer
was negative and a biopsy was recommended. Neelix had an incisional biopsy on
11/8/13. Histopathology results were a nasal adenocarcinoma.
I am sorry now I even mentioned Neelix fighting me at the first vet, because I really think it was more about my making him wear his sweater and not bringing the carrying case than a pain issue.
Past Pertinent History: Had severe URI as kitten and has always had stertor since
then.
I learned a new word. We always called his breathing Darth Vader.
Current Medications: None
Physical Examination: T= 97.5 F, P= 240
bpm, R= 32 bpm. Wt. = 4.64 kg (10.2
lbs.) Bright, alert, and responsive. Body condition score of a 5/9. Pink and moist mucous membranes with a normal
capillary refill time. Stertor noted. Normal air flow from both nostrils. Mass effect (~1cm length) on right side of
nose. No mass effect noted intraorally. Significant dental calculus with
multiple resorptive lesions noted. Both
eyes retro pulse normally. No murmur or
arrhythmia ausculted. Lungs clear with referred upper airway noise.
Unremarkable abdominal palpation. All peripheral lymph nodes within normal
limits. Small (2-3mm) dermal mass left ventral abdomen. The remainder of Neelix’s examination was
unremarkable (rectal, ophthalmic, musculoskeletal, and neurologic).
Diagnostic Tests:
- Review of medical record and biopsy:
- Cryptococcus antigen titer 10/30/13: negative
- Biopsy (incisional) of the right nasal cavity mass
11/13/13: Nasal adenocarcinoma with features that suggest possible
adenoid cystic salivary carcinoma of the soft palate.
i. The specimen from the nasal cavity consists of a malignant
neoplasm derived from the epithelial cells most likely respiratory mucosa, i.e.
a nasal carcinoma
ii. The neoplastic cells vary from round to cuboidal have small
amounts of eosinophilic cytoplasm and round to ovoid nuclei containing finely
granular chromatin and a single small nucleolus.
iii. Neoplastic cells are present in varying sized nests and
nodules surrounded by a thin fibrovascular stroma. In some of the nodules,
neoplastic cells are forming small glandular or acinus-like structures.
iv. This neoplasm has some features that suggest a salivary
gland origin, a finding that makes it possible that this could be a so-called
adenocystic nasal carcinoma that arises from the salivary glandular tissue of
the soft palate rather than the nasal mucosa.
v. The neoplasm extends into the margins of the specimen
submitted
- Chemistry 12/2/13: unremarkable
- CBC 12/2/13: Eosinophils 2580, otherwise unremarkable
- Diagnostics discussed for staging but declined at this
time: 3 view thoracic radiographs and an abdominal ultrasound
- The abdominal ultrasound is a low yield test with
regards to metastatic disease and is recommended to look for concurrent
disease that may affect treatment decisions.
Diagnosis: Nasal
Adenocarcinoma
Treatment Administered: Convenia 37mg SQ for significant resorptive lesions in the
mouth to protect against secondary bacterial infections and discussed oral
Buprenex as the resorptive lesions are likely painful
Medications Recommended: none
Assessment/Tumor
Biology:
Recommendations are below in order of
preference priority:
1.
Definitive radiation therapy
2.
Chemotherapy (alternating
carboplatin/doxorubicin)
3.
Palliative radiation therapy
4. Metronomic
therapy
5. Piroxicam
alone
Neelix was diagnosed with a nasal
adenocarcinoma on biopsy samples. Feline adenocarcinomas are cancers that arise from
epithelial/glandular cells. Tumors are locally invasive and extend into
adjacent normal tissues. In addition to
the local disease, feline adenocarcinomas have the potential to metastasize,
although this is usually less of a problem and generally occurs late in the
disease course; regional lymph nodes and the lungs are the most common place of
disease spread. We recommended staging with thoracic radiographs prior to
radiation therapy or chemotherapy. Prior
to radiation it would be indicated to evaluate both local lymph nodes
(submandibular) to better plan the radiation therapy in case the lymph nodes will
need to be included in the radiation field. There is limited information in the
literature regarding treatment of this tumor type in cats and more is known
with regards to its treatment in dogs. The most information available is in
regards to radiation therapy.
Radiation therapy
Given the behavior of nasal adenocarcinoma,
local therapy, consisting of radiation therapy +/- surgery is the foundation of
treatment. Prognostic variables
associated with this tumor type in dogs are histologic subtype, advanced tumor
stage, and presence of metastatic disease but these variables have not been
reported on in cats. Surgery alone
rarely improves survival times (1-4 months survival time) while definitive
radiation therapy alone can result in median survival times of about 1 year.
A year? I know that is several years in cat time, but not much for the expense and pain considering Neelix's lack of a sense of time and my budget.
Unfortunately, radiation therapy is not offered
at this locality at this time. Radiation
therapy is about $5,500 and would require daily anesthesia Monday-Friday for
about a month with a definitive protocol. A palliative protocol with the intent of stabilizing the tumor for 2-6
months would be about $2,500 and would be significantly fewer treatments and
could be considered if the tumor seems to be causing Neelix discomfort. A CT
scan would be recommended for radiation planning and costs around $1,500. Side effects of radiation include acute
effects (skin irritation, oral irritation, ocular irritation, and oronasal
fistula) and late effects which occur in roughly 5 percent of cats on average 5 years
after radiation (bone necrosis, a new tumor developing, and cataracts). Acute
side effects are more likely to occur with definitive radiation than palliative
radiation but can be seen with either type or protocol. Cats typically tolerate radiation well and
experience fewer side effects than dogs.The type of radiation protocol is
dependent on the radiation oncologist in discussion with the owners.
Holy cow, this is not going to happen. Neelix and I are not roadtripping to torture-ville in Maryland or North Carolina, neighboring states where radiation is available. He would not understand the whys of that at all.
Chemotherapy
In one study of 8 dogs, chemotherapy alone
(alternating doxorubicin and carboplatin) resulted in 50 percent of dogs having a
complete response and an additional 25 percent having a partial response to therapy.
Both of these agents have been used in cats with other types of carcinomas with
varying effect (depending on tumor type). This specific protocol has not been
evaluated in cats with nasal adenocarcinomas so expected response rates for
cats are not available but it would be reasonable as an attempted therapy in
Neelix. As discussed, monitoring responses in the dogs required repeated
advanced imaging so we would recommend completing the protocol as long as he
tolerates the chemotherapy well and he does not show signs of progression.
Neelix is very nervous here in the hospital. It is possible that he may need
sedation for chemotherapy in order for him to be still while it is being
administered and minimize the risk of the agents getting outside of his vein
which could damage the surrounding tissue. Side effects with chemotherapy
include a 1:10 chance of vomiting and diarrhea and a 1:100 chance of life
threatening side effects including severe WBC suppression that would put Neelix
at risk of infection. Routine thoracic radiographs +/- abdominal
ultrasound are recommended throughout therapy to assess response. Please be aware that Neelix will be shedding chemotherapy
metabolites, which can be carcinogenic (cancer causing) in his urine, feces,
and saliva for 48 hours after each dose of chemotherapy. Please wear gloves when handling his urine or
feces and wash your hands well. Please
do not allow pregnant women, women planning to become pregnant,
immunocompromised people, or young children to handle his waste products.
Not only is Neelix very nervous here at the hospital, he would be a toxic waste dump for 48 hours after each treatment.
Metronomic
therapy
An alternative, less aggressive option to
radiation and injectable chemotherapy, is metronomic therapy. Metronomic
therapy involves the administration of one or more oral medications (Piroxicam,
cytoxan, chlorambucil, Palladia, doxycycline) aimed at disrupting the blood
supply to the tumor and thereby inhibiting tumor growth. Additionally, piroxicam (an NSAID) alone is
likely of some benefit since nasal adenocarcinomas in dogs can overexpress
COX-2 (81 percent of canine cases), although again this has not been evaluated in
cats. However, NSAID’s can cause renal damage in
cats so Neelix would need to be monitored really carefully to make sure we do
not cause acute renal failure. The most
common side effect from oral Cytoxan is sterile hemorrhagic cystitis
(irritation to the bladder wall), which would make it uncomfortable for him to
urinate. This side effect is extremely
rare in cats since they have access to a litter box so they can urinate
frequently. Chlorambucil is very well
tolerated in cats but can cause bone marrow suppression with time. The palladia can cause damage to the kidneys
as well but it is usually glomerular damage rather than tubular damage. As
discussed, there is no information available regarding the length of time that
is the most beneficial with this therapy and the recommendation in humans is to
continue until progressive disease is seen.
I have been Google-searching these drugs and have yet to find anything exciting and encouraging. One cat, whose owner started a blog for her pretending to speak in her voice -- I find this really annoying story-telling, because cats are not humans and do not think that way -- was dead three months later despite the Palladia or Piroxicam. The blog just stops, and then there's one more entry three YEARS later explaining the cat died. I feel the Cytoxan is going to be too much, but I so much want the other drugs to keep the tumor small. The drugs themselves do not cost that much, but the office visits and blood work they insist you do every two weeks or monthly or whatever is what runs your bill up to the equivalent of a car payment every month.
I filled out all the paperwork for Fetch-a-Cure. If I got the maximum grant, that would buy us three months treatment, I think, but then I have to volunteer 10 hours a month for a year, which isn't a problem except being immersed in cancerland so intensely for so long. I cry in the shower so no one can see me.
Needed a nap in his favorite chair after exhausting visit to oncologist. |
No comments:
Post a Comment